

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular potassium ion homeostasis (GO:0030007) | 4.70271730 |
| 2 | sodium ion export (GO:0071436) | 4.62626411 |
| 3 | urea metabolic process (GO:0019627) | 4.15337400 |
| 4 | urea cycle (GO:0000050) | 4.15337400 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.11640651 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.11640651 |
| 7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.09326761 |
| 8 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.06826186 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 3.98351377 |
| 10 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.84793847 |
| 11 | tryptophan catabolic process (GO:0006569) | 3.80724923 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 3.80724923 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 3.80724923 |
| 14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.71668862 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.70807989 |
| 16 | tryptophan metabolic process (GO:0006568) | 3.69515579 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 3.67383832 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.67383832 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.63045568 |
| 20 | nitrogen cycle metabolic process (GO:0071941) | 3.60910008 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 3.60240062 |
| 22 | bile acid biosynthetic process (GO:0006699) | 3.60172860 |
| 23 | kynurenine metabolic process (GO:0070189) | 3.55517177 |
| 24 | cerebellar granule cell differentiation (GO:0021707) | 3.50254964 |
| 25 | cell communication by electrical coupling (GO:0010644) | 3.48627470 |
| 26 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.41947016 |
| 27 | cellular sodium ion homeostasis (GO:0006883) | 3.41039774 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.39639686 |
| 29 | protein carboxylation (GO:0018214) | 3.39639686 |
| 30 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.39522330 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.37469993 |
| 32 | regulation of cell communication by electrical coupling (GO:0010649) | 3.36686033 |
| 33 | glutamate secretion (GO:0014047) | 3.34724852 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 3.33686167 |
| 35 | potassium ion import (GO:0010107) | 3.31599870 |
| 36 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.30656642 |
| 37 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.30213435 |
| 38 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.29782796 |
| 39 | detection of calcium ion (GO:0005513) | 3.29167166 |
| 40 | regulation of synaptic vesicle transport (GO:1902803) | 3.29087997 |
| 41 | homocysteine metabolic process (GO:0050667) | 3.28474205 |
| 42 | relaxation of cardiac muscle (GO:0055119) | 3.27939987 |
| 43 | regulation of protein activation cascade (GO:2000257) | 3.26761694 |
| 44 | glutamate metabolic process (GO:0006536) | 3.26560004 |
| 45 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.24258148 |
| 46 | bile acid metabolic process (GO:0008206) | 3.17211470 |
| 47 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.15513469 |
| 48 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.15510912 |
| 49 | nucleobase catabolic process (GO:0046113) | 3.14637014 |
| 50 | potassium ion homeostasis (GO:0055075) | 3.14501540 |
| 51 | glutamate receptor signaling pathway (GO:0007215) | 3.14283434 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 3.13790186 |
| 53 | locomotory exploration behavior (GO:0035641) | 3.12756059 |
| 54 | Golgi to endosome transport (GO:0006895) | 3.09981707 |
| 55 | regulation of fibrinolysis (GO:0051917) | 3.09448730 |
| 56 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.09368494 |
| 57 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.09112641 |
| 58 | cysteine metabolic process (GO:0006534) | 3.08970162 |
| 59 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.08757419 |
| 60 | neuron-neuron synaptic transmission (GO:0007270) | 3.06890175 |
| 61 | cell communication involved in cardiac conduction (GO:0086065) | 3.06601583 |
| 62 | drug catabolic process (GO:0042737) | 3.05689372 |
| 63 | reverse cholesterol transport (GO:0043691) | 3.04866272 |
| 64 | regulation of complement activation (GO:0030449) | 3.04108322 |
| 65 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.02321679 |
| 66 | lysine metabolic process (GO:0006553) | 3.01828879 |
| 67 | lysine catabolic process (GO:0006554) | 3.01828879 |
| 68 | regulation of ARF protein signal transduction (GO:0032012) | 3.01726857 |
| 69 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.01550124 |
| 70 | cholesterol efflux (GO:0033344) | 3.00839160 |
| 71 | tyrosine metabolic process (GO:0006570) | 2.99342355 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.97600833 |
| 73 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.95672065 |
| 74 | glyoxylate metabolic process (GO:0046487) | 2.95257116 |
| 75 | synaptic vesicle maturation (GO:0016188) | 2.94309494 |
| 76 | protein-lipid complex remodeling (GO:0034368) | 2.93781375 |
| 77 | macromolecular complex remodeling (GO:0034367) | 2.93781375 |
| 78 | plasma lipoprotein particle remodeling (GO:0034369) | 2.93781375 |
| 79 | nerve growth factor signaling pathway (GO:0038180) | 2.93542523 |
| 80 | phospholipid homeostasis (GO:0055091) | 2.92517499 |
| 81 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.90494392 |
| 82 | synaptic transmission, glutamatergic (GO:0035249) | 2.88648132 |
| 83 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.86593971 |
| 84 | bile acid and bile salt transport (GO:0015721) | 2.86030300 |
| 85 | L-amino acid import (GO:0043092) | 2.85979123 |
| 86 | righting reflex (GO:0060013) | 2.85521812 |
| 87 | macroautophagy (GO:0016236) | 2.85050105 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 2.84577110 |
| 89 | vesicle transport along microtubule (GO:0047496) | 2.83765454 |
| 90 | sulfur amino acid catabolic process (GO:0000098) | 2.83454610 |
| 91 | indolalkylamine metabolic process (GO:0006586) | 2.83089310 |
| 92 | gamma-aminobutyric acid transport (GO:0015812) | 2.82807766 |
| 93 | serine family amino acid catabolic process (GO:0009071) | 2.81968470 |
| 94 | clathrin coat assembly (GO:0048268) | 2.81438826 |
| 95 | vocalization behavior (GO:0071625) | 2.80862120 |
| 96 | neuronal action potential propagation (GO:0019227) | 2.80830902 |
| 97 | protein targeting to Golgi (GO:0000042) | 2.79941516 |
| 98 | aromatic amino acid family metabolic process (GO:0009072) | 2.79701923 |
| 99 | regulation of bile acid biosynthetic process (GO:0070857) | 2.79052870 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 2.77162960 |
| 101 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.77118113 |
| 102 | serotonin metabolic process (GO:0042428) | 2.77092641 |
| 103 | regulation of beta-amyloid formation (GO:1902003) | 2.76458696 |
| 104 | exploration behavior (GO:0035640) | 2.75020895 |
| 105 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.72952706 |
| 106 | indole-containing compound metabolic process (GO:0042430) | 2.72390190 |
| 107 | exogenous drug catabolic process (GO:0042738) | 2.71897841 |
| 108 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.71732673 |
| 109 | cellular response to ethanol (GO:0071361) | 2.71561155 |
| 110 | phospholipid efflux (GO:0033700) | 2.71353648 |
| 111 | triglyceride homeostasis (GO:0070328) | 2.70376258 |
| 112 | acylglycerol homeostasis (GO:0055090) | 2.70376258 |
| 113 | alpha-amino acid catabolic process (GO:1901606) | 2.69436377 |
| 114 | neuron cell-cell adhesion (GO:0007158) | 2.68854999 |
| 115 | synaptic vesicle exocytosis (GO:0016079) | 2.68589161 |
| 116 | neurotransmitter transport (GO:0006836) | 2.68342518 |
| 117 | coenzyme catabolic process (GO:0009109) | 2.67094006 |
| 118 | establishment of protein localization to Golgi (GO:0072600) | 2.66936084 |
| 119 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.66928587 |
| 120 | amino acid import (GO:0043090) | 2.65779046 |
| 121 | relaxation of smooth muscle (GO:0044557) | 2.65430291 |
| 122 | cellular modified amino acid catabolic process (GO:0042219) | 2.65002897 |
| 123 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.64501809 |
| 124 | regulation of cholesterol homeostasis (GO:2000188) | 2.64477496 |
| 125 | relaxation of muscle (GO:0090075) | 2.64446332 |
| 126 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.64389627 |
| 127 | regulation of neurotransmitter secretion (GO:0046928) | 2.63819333 |
| 128 | negative regulation of cholesterol transport (GO:0032375) | 2.62310895 |
| 129 | negative regulation of sterol transport (GO:0032372) | 2.62310895 |
| 130 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.61807727 |
| 131 | positive regulation of potassium ion transport (GO:0043268) | 2.61246601 |
| 132 | plasma lipoprotein particle assembly (GO:0034377) | 2.59890062 |
| 133 | membrane depolarization during action potential (GO:0086010) | 2.58371058 |
| 134 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.58045034 |
| 135 | alanine transport (GO:0032328) | 2.57881827 |
| 136 | proline transport (GO:0015824) | 2.57248499 |
| 137 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.56097867 |
| 138 | regulation of dendritic spine development (GO:0060998) | 2.55660944 |
| 139 | drug transmembrane transport (GO:0006855) | 2.55166900 |
| 140 | regulation of protein glycosylation (GO:0060049) | 2.54757478 |
| 141 | neurotransmitter secretion (GO:0007269) | 2.54721073 |
| 142 | negative regulation of neurotransmitter transport (GO:0051589) | 2.54485123 |
| 143 | startle response (GO:0001964) | 2.54048008 |
| 144 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.52200407 |
| 145 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.51841965 |
| 146 | synaptic vesicle endocytosis (GO:0048488) | 2.51325030 |
| 147 | positive regulation of muscle hypertrophy (GO:0014742) | 2.51003694 |
| 148 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.51003694 |
| 149 | regulation of cholesterol esterification (GO:0010872) | 2.50530918 |
| 150 | ketone body metabolic process (GO:1902224) | 2.49466297 |
| 151 | inositol phosphate-mediated signaling (GO:0048016) | 2.49393671 |
| 152 | cellular amino acid catabolic process (GO:0009063) | 2.49008212 |
| 153 | regulation of triglyceride catabolic process (GO:0010896) | 2.48520465 |
| 154 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.48488602 |
| 155 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.48356376 |
| 156 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.47740352 |
| 157 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.47635147 |
| 158 | plasma lipoprotein particle clearance (GO:0034381) | 2.47035126 |
| 159 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.46763930 |
| 160 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.46692587 |
| 161 | cell differentiation in hindbrain (GO:0021533) | 2.46332903 |
| 162 | cellular glucuronidation (GO:0052695) | 2.46060362 |
| 163 | long-term synaptic potentiation (GO:0060291) | 2.45750549 |
| 164 | lipoprotein metabolic process (GO:0042157) | 2.45412859 |
| 165 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.45158312 |
| 166 | low-density lipoprotein particle remodeling (GO:0034374) | 2.45000343 |
| 167 | intestinal cholesterol absorption (GO:0030299) | 2.44963253 |
| 168 | organelle transport along microtubule (GO:0072384) | 2.44348516 |
| 169 | phosphorelay signal transduction system (GO:0000160) | 2.41672310 |
| 170 | regulation of synaptic plasticity (GO:0048167) | 2.41239281 |
| 171 | protein localization to synapse (GO:0035418) | 2.39260439 |
| 172 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.38752532 |
| 173 | regulation of neurotransmitter levels (GO:0001505) | 2.37574686 |
| 174 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.36751211 |
| 175 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.36751211 |
| 176 | cardiac conduction (GO:0061337) | 2.36050682 |
| 177 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.35638727 |
| 178 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.35187349 |
| 179 | regulation of neurotransmitter transport (GO:0051588) | 2.34809571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.47500588 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.18343820 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75682671 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53989515 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.49707523 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.45985725 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.15132232 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.10985443 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.05357957 |
| 10 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.01798494 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.97955947 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.95429788 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.93574955 |
| 14 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.86755481 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.85811630 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85441958 |
| 17 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.81296318 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.79194674 |
| 19 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78243596 |
| 20 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.76138262 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70082272 |
| 22 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.66779740 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66071484 |
| 24 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56707315 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.55205837 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.52683716 |
| 27 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.51272313 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50488794 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47784812 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46143353 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44185064 |
| 32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44151382 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43321357 |
| 34 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.40820604 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40756751 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40184006 |
| 37 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39799837 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37989191 |
| 39 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37793469 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36227090 |
| 41 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35613901 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.35418677 |
| 43 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34372535 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34355622 |
| 45 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.34107597 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33117827 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32981299 |
| 48 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31478736 |
| 49 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29978049 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.29680336 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.29680336 |
| 52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29679692 |
| 53 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29657452 |
| 54 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.28921129 |
| 55 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28582485 |
| 56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27314778 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25834814 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25427507 |
| 59 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24200845 |
| 60 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24071487 |
| 61 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.23273801 |
| 62 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22231646 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21912006 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21660844 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.21373035 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20978199 |
| 67 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.20856885 |
| 68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20846400 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19547984 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19360943 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19236827 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19209462 |
| 73 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19206178 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18833530 |
| 75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18173007 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18006739 |
| 77 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.17982099 |
| 78 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.17982099 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 1.16466320 |
| 80 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.16222662 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15614052 |
| 82 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.14901581 |
| 83 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.14467626 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14417669 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14166444 |
| 86 | AR_19668381_ChIP-Seq_PC3_Human | 1.13980499 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.12247810 |
| 88 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11026076 |
| 89 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10717853 |
| 90 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.10160644 |
| 91 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09905193 |
| 92 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08368471 |
| 93 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08028125 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05858085 |
| 95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05623022 |
| 96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.05418225 |
| 97 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05140866 |
| 98 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.05113558 |
| 99 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04988604 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04268110 |
| 101 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.04002594 |
| 102 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03918673 |
| 103 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03902109 |
| 104 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03869853 |
| 105 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03038415 |
| 106 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02444438 |
| 107 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02122180 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00407160 |
| 109 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.00318026 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99765786 |
| 111 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99406174 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99000625 |
| 113 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98097536 |
| 114 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97411056 |
| 115 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96591307 |
| 116 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96565939 |
| 117 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96438700 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96438700 |
| 119 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96025241 |
| 120 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95482604 |
| 121 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94817178 |
| 122 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.94060089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.83630020 |
| 2 | MP0005360_urolithiasis | 5.59614510 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.73365882 |
| 4 | MP0005365_abnormal_bile_salt | 4.46886847 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.73062261 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.50976735 |
| 7 | MP0003252_abnormal_bile_duct | 3.40861952 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 3.32299257 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.11964218 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.79101838 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.61327391 |
| 12 | MP0003195_calcinosis | 2.52098915 |
| 13 | MP0004270_analgesia | 2.48249710 |
| 14 | MP0008057_abnormal_DNA_replication | 2.41244349 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.24007726 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.01017658 |
| 17 | MP0003868_abnormal_feces_composition | 1.98895466 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 1.88061942 |
| 19 | MP0002009_preneoplasia | 1.83635417 |
| 20 | MP0008569_lethality_at_weaning | 1.78493936 |
| 21 | MP0009745_abnormal_behavioral_response | 1.78467445 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.77532534 |
| 23 | MP0005332_abnormal_amino_acid | 1.76152475 |
| 24 | MP0003880_abnormal_central_pattern | 1.68864825 |
| 25 | MP0009046_muscle_twitch | 1.65561063 |
| 26 | MP0004484_altered_response_of | 1.61825808 |
| 27 | MP0004742_abnormal_vestibular_system | 1.59516220 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.58734404 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.58345155 |
| 30 | MP0002064_seizures | 1.58279649 |
| 31 | MP0004036_abnormal_muscle_relaxation | 1.57519698 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.57425551 |
| 33 | MP0004147_increased_porphyrin_level | 1.54279401 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.52460800 |
| 35 | MP0005248_abnormal_Harderian_gland | 1.49006422 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.45900991 |
| 37 | MP0005083_abnormal_biliary_tract | 1.43991875 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.40207095 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.38760170 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.38368818 |
| 41 | MP0000920_abnormal_myelination | 1.37334006 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.35686804 |
| 43 | MP0001486_abnormal_startle_reflex | 1.33494616 |
| 44 | MP0000609_abnormal_liver_physiology | 1.32040279 |
| 45 | MP0000604_amyloidosis | 1.31153429 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.30806989 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.29801593 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.29019527 |
| 49 | MP0003329_amyloid_beta_deposits | 1.28285076 |
| 50 | MP0004130_abnormal_muscle_cell | 1.27978235 |
| 51 | MP0004043_abnormal_pH_regulation | 1.26344078 |
| 52 | MP0003633_abnormal_nervous_system | 1.25592388 |
| 53 | MP0002734_abnormal_mechanical_nocicepti | 1.23648171 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.23503348 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.22820617 |
| 56 | MP0003690_abnormal_glial_cell | 1.20811428 |
| 57 | MP0001177_atelectasis | 1.19905461 |
| 58 | MP0003787_abnormal_imprinting | 1.19084764 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.18047532 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.17110373 |
| 61 | MP0006276_abnormal_autonomic_nervous | 1.16274130 |
| 62 | MP0000751_myopathy | 1.15775737 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.15231645 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.14461257 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.12033823 |
| 66 | MP0003890_abnormal_embryonic-extraembry | 1.09924104 |
| 67 | MP0002229_neurodegeneration | 1.09779400 |
| 68 | MP0002184_abnormal_innervation | 1.09242035 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.08256493 |
| 70 | MP0002822_catalepsy | 1.05870519 |
| 71 | MP0009697_abnormal_copulation | 1.05833216 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.05728825 |
| 73 | MP0004924_abnormal_behavior | 1.05728825 |
| 74 | MP0003300_gastrointestinal_ulcer | 1.05354740 |
| 75 | MP0000749_muscle_degeneration | 1.05304679 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.04919047 |
| 77 | MP0003634_abnormal_glial_cell | 1.04538621 |
| 78 | MP0001440_abnormal_grooming_behavior | 1.03380923 |
| 79 | MP0004811_abnormal_neuron_physiology | 1.01935911 |
| 80 | MP0004858_abnormal_nervous_system | 1.01538078 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.98867761 |
| 82 | MP0000747_muscle_weakness | 0.98820676 |
| 83 | MP0002882_abnormal_neuron_morphology | 0.98698726 |
| 84 | MP0003631_nervous_system_phenotype | 0.97511827 |
| 85 | MP0004233_abnormal_muscle_weight | 0.97130788 |
| 86 | MP0003950_abnormal_plasma_membrane | 0.96813757 |
| 87 | MP0000778_abnormal_nervous_system | 0.96732342 |
| 88 | MP0002272_abnormal_nervous_system | 0.95598556 |
| 89 | MP0001970_abnormal_pain_threshold | 0.94671085 |
| 90 | MP0003879_abnormal_hair_cell | 0.94374491 |
| 91 | MP0002557_abnormal_social/conspecific_i | 0.93381284 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.92659206 |
| 93 | MP0005535_abnormal_body_temperature | 0.92553487 |
| 94 | MP0005187_abnormal_penis_morphology | 0.91339327 |
| 95 | MP0010678_abnormal_skin_adnexa | 0.90941605 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.90020703 |
| 97 | MP0009840_abnormal_foam_cell | 0.89060085 |
| 98 | MP0002067_abnormal_sensory_capabilities | 0.87890780 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.87504007 |
| 100 | MP0003045_fibrosis | 0.87303289 |
| 101 | MP0001984_abnormal_olfaction | 0.85354038 |
| 102 | MP0002269_muscular_atrophy | 0.84846324 |
| 103 | MP0004264_abnormal_extraembryonic_tissu | 0.83264325 |
| 104 | MP0004134_abnormal_chest_morphology | 0.82807529 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82444868 |
| 106 | MP0002736_abnormal_nociception_after | 0.82090860 |
| 107 | MP0005620_abnormal_muscle_contractility | 0.81105306 |
| 108 | MP0000427_abnormal_hair_cycle | 0.80225179 |
| 109 | MP0005448_abnormal_energy_balance | 0.79130256 |
| 110 | MP0004085_abnormal_heartbeat | 0.78864529 |
| 111 | MP0002638_abnormal_pupillary_reflex | 0.78206789 |
| 112 | MP0001661_extended_life_span | 0.77839430 |
| 113 | MP0001756_abnormal_urination | 0.77723892 |
| 114 | MP0000003_abnormal_adipose_tissue | 0.77486556 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.76613002 |
| 116 | MP0005647_abnormal_sex_gland | 0.76519374 |
| 117 | MP0002733_abnormal_thermal_nociception | 0.74158322 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.73885575 |
| 119 | MP0003632_abnormal_nervous_system | 0.72828692 |
| 120 | MP0000759_abnormal_skeletal_muscle | 0.72565476 |
| 121 | MP0002090_abnormal_vision | 0.71009324 |
| 122 | MP0005551_abnormal_eye_electrophysiolog | 0.70924739 |
| 123 | MP0000639_abnormal_adrenal_gland | 0.69895377 |
| 124 | MP0002069_abnormal_eating/drinking_beha | 0.69673431 |
| 125 | MP0005334_abnormal_fat_pad | 0.69085059 |
| 126 | MP0004087_abnormal_muscle_fiber | 0.68999785 |
| 127 | MP0005623_abnormal_meninges_morphology | 0.68193969 |
| 128 | MP0001764_abnormal_homeostasis | 0.68099938 |
| 129 | MP0003075_altered_response_to | 0.66585000 |
| 130 | MP0001502_abnormal_circadian_rhythm | 0.65941417 |
| 131 | MP0008874_decreased_physiological_sensi | 0.65123090 |
| 132 | MP0005645_abnormal_hypothalamus_physiol | 0.64294575 |
| 133 | MP0004885_abnormal_endolymph | 0.64085139 |
| 134 | MP0002896_abnormal_bone_mineralization | 0.63210310 |
| 135 | MP0003953_abnormal_hormone_level | 0.62520401 |
| 136 | MP0002066_abnormal_motor_capabilities/c | 0.60909101 |
| 137 | MP0002168_other_aberrant_phenotype | 0.60735554 |
| 138 | MP0002928_abnormal_bile_duct | 0.60338264 |
| 139 | MP0000955_abnormal_spinal_cord | 0.60221250 |
| 140 | MP0001324_abnormal_eye_pigmentation | 0.60018356 |
| 141 | MP0002971_abnormal_brown_adipose | 0.59879040 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.58747264 |
| 143 | MP0000579_abnormal_nail_morphology | 0.56939408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 4.70461510 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.45944807 |
| 3 | Epidermoid cyst (HP:0200040) | 4.20204145 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.08228275 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.05233765 |
| 6 | Xanthomatosis (HP:0000991) | 3.91359852 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.68358166 |
| 8 | Complement deficiency (HP:0004431) | 3.64051466 |
| 9 | Focal motor seizures (HP:0011153) | 3.56165102 |
| 10 | Hyperventilation (HP:0002883) | 3.47277067 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.29486913 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 3.17878257 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 3.10225477 |
| 14 | Truncal ataxia (HP:0002078) | 3.05181213 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.03725604 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.01115225 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.94429940 |
| 18 | Pheochromocytoma (HP:0002666) | 2.93561396 |
| 19 | Focal seizures (HP:0007359) | 2.91600614 |
| 20 | Hypochromic microcytic anemia (HP:0004840) | 2.89119846 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 2.83248007 |
| 22 | Bundle branch block (HP:0011710) | 2.82659649 |
| 23 | Fat malabsorption (HP:0002630) | 2.77479953 |
| 24 | Excessive salivation (HP:0003781) | 2.76117479 |
| 25 | Drooling (HP:0002307) | 2.76117479 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.73972429 |
| 27 | Ankle clonus (HP:0011448) | 2.72519708 |
| 28 | Acanthocytosis (HP:0001927) | 2.71894358 |
| 29 | Fetal akinesia sequence (HP:0001989) | 2.69141933 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 2.66257105 |
| 31 | Joint hemorrhage (HP:0005261) | 2.64925936 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.64167488 |
| 33 | Epileptic encephalopathy (HP:0200134) | 2.61741223 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.60937489 |
| 35 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.59845919 |
| 36 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.59845919 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.53268635 |
| 38 | Thyroid carcinoma (HP:0002890) | 2.51029093 |
| 39 | Neuroendocrine neoplasm (HP:0100634) | 2.49727797 |
| 40 | Ketosis (HP:0001946) | 2.48180704 |
| 41 | Fair hair (HP:0002286) | 2.46816529 |
| 42 | Skin nodule (HP:0200036) | 2.46656261 |
| 43 | Generalized hypopigmentation of hair (HP:0011358) | 2.45124457 |
| 44 | Lower limb muscle weakness (HP:0007340) | 2.44610544 |
| 45 | Exercise-induced muscle cramps (HP:0003710) | 2.42503688 |
| 46 | Epileptiform EEG discharges (HP:0011182) | 2.42316191 |
| 47 | Abnormal social behavior (HP:0012433) | 2.41561174 |
| 48 | Impaired social interactions (HP:0000735) | 2.41561174 |
| 49 | Status epilepticus (HP:0002133) | 2.40795369 |
| 50 | Hypercholesterolemia (HP:0003124) | 2.39139884 |
| 51 | Syncope (HP:0001279) | 2.37218587 |
| 52 | Sensorimotor neuropathy (HP:0007141) | 2.36538134 |
| 53 | Blue irides (HP:0000635) | 2.36172179 |
| 54 | Chronic hepatic failure (HP:0100626) | 2.35157026 |
| 55 | Scanning speech (HP:0002168) | 2.34734494 |
| 56 | Supranuclear gaze palsy (HP:0000605) | 2.34587663 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.33315460 |
| 58 | Akinesia (HP:0002304) | 2.33073342 |
| 59 | Dysmetria (HP:0001310) | 2.31290759 |
| 60 | Impaired vibratory sensation (HP:0002495) | 2.31232820 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.30708203 |
| 62 | Abnormality of the lower motor neuron (HP:0002366) | 2.30374701 |
| 63 | Autoamputation (HP:0001218) | 2.30031571 |
| 64 | Abnormality of complement system (HP:0005339) | 2.29565281 |
| 65 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.28747213 |
| 66 | Hemiparesis (HP:0001269) | 2.26418946 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.26292406 |
| 68 | Abnormality of methionine metabolism (HP:0010901) | 2.25889385 |
| 69 | Absence seizures (HP:0002121) | 2.25174733 |
| 70 | Ventricular fibrillation (HP:0001663) | 2.24546136 |
| 71 | Hyperglycinemia (HP:0002154) | 2.23373630 |
| 72 | Hypsarrhythmia (HP:0002521) | 2.22583820 |
| 73 | Postural tremor (HP:0002174) | 2.21976189 |
| 74 | Progressive cerebellar ataxia (HP:0002073) | 2.20028613 |
| 75 | Generalized tonic-clonic seizures (HP:0002069) | 2.18517771 |
| 76 | Febrile seizures (HP:0002373) | 2.16996338 |
| 77 | Neurofibrillary tangles (HP:0002185) | 2.16068787 |
| 78 | Action tremor (HP:0002345) | 2.14124841 |
| 79 | Sudden death (HP:0001699) | 2.14084401 |
| 80 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.13993353 |
| 81 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.13949751 |
| 82 | Papilledema (HP:0001085) | 2.13081291 |
| 83 | Termporal pattern (HP:0011008) | 2.13053771 |
| 84 | Insidious onset (HP:0003587) | 2.13053771 |
| 85 | Atonic seizures (HP:0010819) | 2.12148445 |
| 86 | Poor eye contact (HP:0000817) | 2.11601475 |
| 87 | Myokymia (HP:0002411) | 2.10782712 |
| 88 | Postural instability (HP:0002172) | 2.10660281 |
| 89 | Hepatocellular carcinoma (HP:0001402) | 2.10050416 |
| 90 | Upper motor neuron abnormality (HP:0002127) | 2.09906922 |
| 91 | Hyperammonemia (HP:0001987) | 2.09298208 |
| 92 | Spontaneous abortion (HP:0005268) | 2.09069260 |
| 93 | Generalized myoclonic seizures (HP:0002123) | 2.08101513 |
| 94 | Depression (HP:0000716) | 2.05804491 |
| 95 | Myocardial infarction (HP:0001658) | 2.05490743 |
| 96 | Ketoacidosis (HP:0001993) | 2.05417520 |
| 97 | Hyporeflexia of lower limbs (HP:0002600) | 2.03701297 |
| 98 | Macroorchidism (HP:0000053) | 2.02470740 |
| 99 | Tetraplegia (HP:0002445) | 2.01443329 |
| 100 | Mitral stenosis (HP:0001718) | 2.01128718 |
| 101 | Papillary thyroid carcinoma (HP:0002895) | 2.00574117 |
| 102 | Hyperglycemia (HP:0003074) | 2.00424557 |
| 103 | Abnormality of the corticospinal tract (HP:0002492) | 2.00203663 |
| 104 | Increased circulating renin level (HP:0000848) | 2.00015865 |
| 105 | Dialeptic seizures (HP:0011146) | 1.99858395 |
| 106 | Short chin (HP:0000331) | 1.98963812 |
| 107 | Arterial tortuosity (HP:0005116) | 1.98851644 |
| 108 | Hypoglycemic coma (HP:0001325) | 1.98695994 |
| 109 | Gait ataxia (HP:0002066) | 1.97408585 |
| 110 | Dysmetric saccades (HP:0000641) | 1.96810799 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 1.96698645 |
| 112 | Urinary urgency (HP:0000012) | 1.95943475 |
| 113 | Dysdiadochokinesis (HP:0002075) | 1.95405994 |
| 114 | Broad-based gait (HP:0002136) | 1.95049378 |
| 115 | Subacute progressive viral hepatitis (HP:0006572) | 1.93951505 |
| 116 | Abnormality of purine metabolism (HP:0004352) | 1.93256751 |
| 117 | Calf muscle hypertrophy (HP:0008981) | 1.92887686 |
| 118 | Clonus (HP:0002169) | 1.89836582 |
| 119 | Absent speech (HP:0001344) | 1.89345184 |
| 120 | Nemaline bodies (HP:0003798) | 1.86423447 |
| 121 | Turricephaly (HP:0000262) | 1.86304591 |
| 122 | Abnormality of saccadic eye movements (HP:0000570) | 1.86179910 |
| 123 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.85873795 |
| 124 | Genetic anticipation (HP:0003743) | 1.85627370 |
| 125 | Exercise-induced myalgia (HP:0003738) | 1.84417457 |
| 126 | Overgrowth (HP:0001548) | 1.84035741 |
| 127 | Amyotrophic lateral sclerosis (HP:0007354) | 1.83625182 |
| 128 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.82201240 |
| 129 | Tetraparesis (HP:0002273) | 1.80998804 |
| 130 | Gaze-evoked nystagmus (HP:0000640) | 1.80934755 |
| 131 | Gout (HP:0001997) | 1.80076407 |
| 132 | Protruding tongue (HP:0010808) | 1.79191187 |
| 133 | Hemiplegia (HP:0002301) | 1.78882540 |
| 134 | Relative macrocephaly (HP:0004482) | 1.78087781 |
| 135 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.77669518 |
| 136 | Spastic gait (HP:0002064) | 1.77479069 |
| 137 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.77140839 |
| 138 | Visual hallucinations (HP:0002367) | 1.76453649 |
| 139 | Diminished movement (HP:0002374) | 1.76411530 |
| 140 | Muscle fiber inclusion bodies (HP:0100299) | 1.76200615 |
| 141 | Mutism (HP:0002300) | 1.75674531 |
| 142 | Widely spaced teeth (HP:0000687) | 1.75651431 |
| 143 | Enlarged kidneys (HP:0000105) | 1.74737450 |
| 144 | Abnormality of nucleobase metabolism (HP:0010932) | 1.73532894 |
| 145 | Abnormality of the ischium (HP:0003174) | 1.72281721 |
| 146 | Cortical dysplasia (HP:0002539) | 1.70925918 |
| 147 | Vascular calcification (HP:0004934) | 1.69947828 |
| 148 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.69603987 |
| 149 | Abnormality of glycine metabolism (HP:0010895) | 1.69603987 |
| 150 | Hepatoblastoma (HP:0002884) | 1.68603355 |
| 151 | Paraplegia (HP:0010550) | 1.66029873 |
| 152 | Abnormality of salivation (HP:0100755) | 1.65562886 |
| 153 | Intention tremor (HP:0002080) | 1.65235814 |
| 154 | Potter facies (HP:0002009) | 1.64168304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.46221705 |
| 2 | NTRK3 | 3.35575899 |
| 3 | FRK | 3.34813446 |
| 4 | MAP3K4 | 3.00540023 |
| 5 | CASK | 2.81055742 |
| 6 | MARK1 | 2.37104919 |
| 7 | MAP3K9 | 2.34955121 |
| 8 | AKT3 | 2.23616705 |
| 9 | MAP2K7 | 2.19561201 |
| 10 | LATS1 | 2.18960974 |
| 11 | INSRR | 2.18452836 |
| 12 | MAP2K4 | 2.18409315 |
| 13 | DAPK2 | 2.10349651 |
| 14 | MAP3K2 | 2.01487243 |
| 15 | SGK2 | 1.92572254 |
| 16 | SIK1 | 1.77842923 |
| 17 | OBSCN | 1.76848601 |
| 18 | SGK3 | 1.72494829 |
| 19 | ERBB3 | 1.68907766 |
| 20 | PLK2 | 1.66806696 |
| 21 | SCYL2 | 1.60532710 |
| 22 | ERBB4 | 1.58486620 |
| 23 | PNCK | 1.51423677 |
| 24 | RIPK4 | 1.49512112 |
| 25 | MINK1 | 1.47349635 |
| 26 | CAMK1G | 1.45991679 |
| 27 | CAMKK1 | 1.44263356 |
| 28 | FGFR2 | 1.44194968 |
| 29 | BMPR2 | 1.43691679 |
| 30 | PHKG1 | 1.43543989 |
| 31 | PHKG2 | 1.43543989 |
| 32 | CAMK1D | 1.42059658 |
| 33 | SGK223 | 1.38554783 |
| 34 | SGK494 | 1.38554783 |
| 35 | TAOK3 | 1.28100255 |
| 36 | PAK6 | 1.22880554 |
| 37 | DAPK1 | 1.20748481 |
| 38 | TRPM7 | 1.18955144 |
| 39 | NEK9 | 1.11625899 |
| 40 | MAPK12 | 1.10750793 |
| 41 | KSR1 | 1.10312787 |
| 42 | NEK6 | 1.10044522 |
| 43 | PINK1 | 1.09845939 |
| 44 | NTRK1 | 1.09071767 |
| 45 | CAMKK2 | 1.06773483 |
| 46 | LATS2 | 1.04972149 |
| 47 | STK38 | 1.02724399 |
| 48 | FGFR3 | 1.02052433 |
| 49 | OXSR1 | 1.01838723 |
| 50 | RET | 1.00757380 |
| 51 | PRKD3 | 0.98305134 |
| 52 | WNK1 | 0.95597489 |
| 53 | NTRK2 | 0.94807650 |
| 54 | PRKCG | 0.92854779 |
| 55 | SGK1 | 0.92420991 |
| 56 | CDK5 | 0.90966885 |
| 57 | KSR2 | 0.89532820 |
| 58 | BRD4 | 0.87833910 |
| 59 | PRKCH | 0.84816326 |
| 60 | UHMK1 | 0.81917694 |
| 61 | IRAK2 | 0.81742842 |
| 62 | RAF1 | 0.80350595 |
| 63 | WNK3 | 0.79860261 |
| 64 | JAK1 | 0.79741420 |
| 65 | FER | 0.79546295 |
| 66 | FGFR4 | 0.79057247 |
| 67 | YES1 | 0.78826994 |
| 68 | PDK1 | 0.76745565 |
| 69 | EEF2K | 0.74967771 |
| 70 | PTK2 | 0.72864768 |
| 71 | MAP3K7 | 0.72834200 |
| 72 | MAP4K2 | 0.72833211 |
| 73 | CAMK2A | 0.71739266 |
| 74 | RIPK1 | 0.71438560 |
| 75 | CAMK2G | 0.71339018 |
| 76 | CAMK2D | 0.68324420 |
| 77 | NUAK1 | 0.68314807 |
| 78 | PDPK1 | 0.67981278 |
| 79 | PAK3 | 0.67910292 |
| 80 | STK11 | 0.66188329 |
| 81 | PIK3CG | 0.66067854 |
| 82 | PDK4 | 0.65778454 |
| 83 | PDK3 | 0.65778454 |
| 84 | CDK12 | 0.65148743 |
| 85 | MET | 0.65083052 |
| 86 | PDGFRA | 0.64933617 |
| 87 | MST1R | 0.62906626 |
| 88 | PDK2 | 0.62338609 |
| 89 | PRKCZ | 0.61794088 |
| 90 | MAPK13 | 0.60755907 |
| 91 | RPS6KB1 | 0.60721532 |
| 92 | PRKAA1 | 0.60486614 |
| 93 | MUSK | 0.60318057 |
| 94 | MAP3K1 | 0.60248792 |
| 95 | STK24 | 0.59978890 |
| 96 | CAMK1 | 0.58796838 |
| 97 | EPHA3 | 0.58650787 |
| 98 | PIK3CA | 0.57868045 |
| 99 | PDGFRB | 0.56984836 |
| 100 | FGFR1 | 0.54449734 |
| 101 | DMPK | 0.54029572 |
| 102 | NEK1 | 0.53856851 |
| 103 | RPS6KA3 | 0.52850922 |
| 104 | PRKG1 | 0.52513047 |
| 105 | IRAK1 | 0.51120591 |
| 106 | STK39 | 0.50628306 |
| 107 | RPS6KA2 | 0.50287410 |
| 108 | PRPF4B | 0.49805243 |
| 109 | SIK3 | 0.49770678 |
| 110 | MAP2K1 | 0.49079291 |
| 111 | CSNK1G2 | 0.48976203 |
| 112 | JAK2 | 0.47028951 |
| 113 | CSNK1A1L | 0.46999972 |
| 114 | STK3 | 0.46241858 |
| 115 | GRK5 | 0.45118852 |
| 116 | CAMK2B | 0.45046174 |
| 117 | PRKAA2 | 0.44618282 |
| 118 | MARK2 | 0.44300224 |
| 119 | SIK2 | 0.43993781 |
| 120 | CAMK4 | 0.43686312 |
| 121 | PTK6 | 0.43195267 |
| 122 | PRKCQ | 0.42141743 |
| 123 | PRKCE | 0.39942585 |
| 124 | MAPK10 | 0.38041809 |
| 125 | CCNB1 | 0.37899376 |
| 126 | PRKCB | 0.37820340 |
| 127 | PRKACG | 0.34449867 |
| 128 | FYN | 0.33985528 |
| 129 | MAP3K12 | 0.33853057 |
| 130 | STK38L | 0.33791711 |
| 131 | MAPK7 | 0.33172969 |
| 132 | BCR | 0.33050240 |
| 133 | PTK2B | 0.32902069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.86965955 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.21254931 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87592211 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63755056 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.11274340 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83741914 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81861353 |
| 8 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.81635464 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69807297 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69586315 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.68828583 |
| 12 | Circadian rhythm_Homo sapiens_hsa04710 | 1.67530501 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 1.60543299 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.58171803 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.55274757 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.53584739 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.38752719 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.29901681 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24991056 |
| 20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21407752 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.20035858 |
| 22 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17548036 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.16739726 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16473978 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13444549 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11896679 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.10837057 |
| 28 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.10717785 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.09508290 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09485282 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.09169747 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08223872 |
| 33 | Circadian entrainment_Homo sapiens_hsa04713 | 1.06659580 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.04132449 |
| 35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03280226 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03095595 |
| 37 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.01888565 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01211722 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.00765782 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00246950 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.98715972 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98072098 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96779243 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96442987 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95470055 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93456795 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.93451690 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.93114617 |
| 49 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91535754 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90883919 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 0.89377790 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 0.89228419 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89038459 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85489013 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83650279 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83558992 |
| 57 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83366766 |
| 58 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83361467 |
| 59 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82301409 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82294571 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82080602 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81611100 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80556770 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78861099 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78733468 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.78633687 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77651346 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77588565 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.76315048 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76177206 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.75502784 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75306438 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72913836 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72779749 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.72642372 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71655017 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70373186 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69780517 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69078306 |
| 80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68626246 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68516012 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68191962 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67808163 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67568997 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67522934 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67245398 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.66273140 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65915581 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64609169 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64427157 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64168740 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64081863 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63264869 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.61628610 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61396828 |
| 96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61101576 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61042337 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.60985624 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.59815130 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59725451 |
| 101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59555872 |
| 102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58826377 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58817491 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58208063 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57501278 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56344294 |
| 107 | Long-term depression_Homo sapiens_hsa04730 | 0.54830415 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54320430 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53751939 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52347188 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51308331 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50751935 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50259647 |
| 114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48919431 |
| 115 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48103581 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47569719 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45237090 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44840579 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44466077 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43546282 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.43538415 |
| 122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43067428 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40524562 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39783270 |
| 125 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39613552 |
| 126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39027057 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37644391 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37534262 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37248243 |
| 130 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36307584 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.35724091 |
| 132 | Axon guidance_Homo sapiens_hsa04360 | 0.35494770 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35247958 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35171873 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33486340 |

